Results 31 to 40 of about 39,162 (280)

A case of simultaneous breast cancer and ovarian cancer based on a hereditary breast and ovarian cancer syndrome [PDF]

, 2023
We experienced a relatively rare case of synchronous breast and ovarian cancer in a patient with hereditary breast and ovarian cancer syndrome (HBOC).
Komori, Koji, Mori, Masahiko, Kotaka, Saki, Ouchi, Akira, Shimizu, Yasuhiro, Kotani, Haruru, Okuno, Masataka, Tsubouchi, Hirofumi, Yasui, Hiroaki, Yoshimura, Akiyo, Suzuki, Shiro   +10 more
core   +1 more source

Survival outcome in endometrial cancer patients according to hereditary predisposition

Taiwanese Journal of Obstetrics & Gynecology, 2015
Objective: A familial history of ovarian cancer/breast cancer is considered a significant prognostic factor for ovarian cancer. We investigated hereditary factors by examining the incidence of synchronous malignancy in patients with endometrial cancer ...
Heon Jong Yoo, Myong Cheol Lim, Yedong Son, Sang-Soo Seo, Sokbom Kang, Sun Ho Kim, Chong Woo Yoo, Sang-Yoon Park   +7 more
doaj   +1 more source

MEDICAL AND GENETIC COUNSELING OF HEREDITARY BREAST AND OVARIAN CANCER

Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, 2018
Hereditary breast and ovarian cancer is one of the most common genetic pathology. Medical and genetic counseling of patients with hereditary breast and ovarian cancer and their families plays the important role in cancer care, as it helps to develop the ...
S. A. Laptiev, M. A. Korzhenevskaia, A. P. Sokolenko, A. G. Iyevleva, E. N. Imyanitov   +4 more
doaj   +1 more source

Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History

JAMA Network Open, 2020
IMPORTANCE Pathogenic DNA variants associated with familial hypercholesterolemia, hereditary breast and ovarian cancer syndrome, and Lynch syndrome are widely recognized as clinically important and actionable when identified, leading some clinicians to ...
A. Patel, Min-Xian Wang, A. Fahed, H. Mason-Suares, Deanna G. Brockman, R. Pelletier, S. Amr, K. Machini, Megan H. Hawley, Leora Witkowski, C. Koch, Anthony A. Philippakis, C. Cassa, P. Ellinor, S. Kathiresan, Kenney Ng, Matthew S. Lebo, A. Khera   +17 more
semanticscholar   +1 more source

Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer

Cancers, 2022
Simple Summary Male breast cancer (mBC) is a rare disease associated with a high prevalence of pathogenic germline variants (PVs) in the BRCA2 gene. However, data regarding other breast cancer (BC) predisposition genes are limited or conflicting.
Muriel Rolfes, J. Borde, K. Möllenhoff, Mohamad Kayali, C. Ernst, A. Gehrig, C. Sutter, J. Ramser, D. Niederacher, J. Horváth, N. Arnold, A. Meindl, B. Auber, A. Rump, S. Wang-Gohrke, J. Ritter, J. Hentschel, H. Thiele, J. Altmüller, P. Nürnberg, K. Rhiem, C. Engel, B. Wappenschmidt, R. Schmutzler, E. Hahnen, J. Hauke   +25 more
semanticscholar   +1 more source

Laboratory assessment of the risks of malignant neoplasms of the mammary gland and ovaries

Репродуктивная эндокринология, 2018
In most cases, oncological diseases are hereditary: for breast cancer – 5–10%, and for ovarian cancer – 10–17%, and associated with the support of mutations in certain genes derived from one of the parents.
А. В. Шумицький, О. А. Бурка, І. В. Сідорова   +2 more
doaj   +1 more source

Age and Geographical Distribution in Families with BRCA1/BRCA2 Mutations in the Slovak Republic

Hereditary Cancer in Clinical Practice, 2006
Molecular diagnostics of hereditary breast and/or ovarian cancer is mainly based on detection of BRCA1 and BRCA2 germline mutations in suspected families.
Ciernikova Sona, Tomka Miroslav, Kovac Michal, Stevurkova Viola, Zajac Vladimir   +4 more
doaj   +1 more source

The Prevention of Hereditary Breast and Ovarian Cancer: A Personal View

Hereditary Cancer in Clinical Practice, 2004
Options for the prevention of hereditary breast and ovarian cancer include screening, preventive surgery and chemoprevention. Screening studies with magnetic resonance imaging of the breast are promising but the technology is not widespread and MRI is ...
Narod Steven
doaj   +1 more source

Mutational Landscape for Indian Hereditary Breast and Ovarian Cancer Cohort Suggests Need for Identifying Population Specific Genes and Biomarkers for Screening

Frontiers in Oncology, 2021
Background Breast and ovarian cancers are the most prevalent cancers and one of the leading causes of death in Indian women. The healthcare burden of breast and ovarian cancers and the rise in mortality rate are worrying and stress the need for early ...
M. Kadri, K. Patel, Poonam Bhargava, Franky D. Shah, Nutan Badgujar, Bhoomi Tarapara, P. Patel, M. Shaikh, K. Shah, Apurva Patel, S. Pandya, H. Vora, C. Joshi, Madhvi Joshi   +13 more
semanticscholar   +1 more source

Invasive micropapillary carcinoma of the breast and bilateral ovarian mature cystic teratoma with benign Brenner tumor in a postmenopausal woman – An uncommon occurrence

Indian Journal of Pathology and Microbiology, 2023
The synchronous occurrence of bilateral ovarian tumors and breast malignancy often raise the suspicion of a Krukenberg tumor or a hereditary breast and ovarian cancer syndrome, both of which are uncommon in clinical practice.
Pavithra Ayyanar, Suvradeep Mitra, Mohammed Imaduddin, Dillip K. Muduly   +3 more
doaj   +1 more source